One patient in the MLPA-negative DMD group who had clinical findings and muscle histopathology consistent with dystrophinopathy but with no variant found was believed to have a regulatory/promoter or deep intronic alteration. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.